Neonatal genetics of gene expression reveal potential origins of autoimmune and allergic disease risk.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
28 07 2020
Historique:
received: 23 07 2019
accepted: 29 06 2020
entrez: 30 7 2020
pubmed: 30 7 2020
medline: 22 9 2020
Statut: epublish

Résumé

Chronic immune-mediated diseases of adulthood often originate in early childhood. To investigate genetic associations between neonatal immunity and disease, we map expression quantitative trait loci (eQTLs) in resting myeloid cells and CD4

Identifiants

pubmed: 32724101
doi: 10.1038/s41467-020-17477-x
pii: 10.1038/s41467-020-17477-x
pmc: PMC7387553
doi:

Substances chimiques

BTN3A2 protein, human 0
Butyrophilins 0
HLA-C Antigens 0
CTSH protein, human EC 3.4.22.16
Cathepsin H EC 3.4.22.16

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3761

Subventions

Organisme : Medical Research Council
ID : MR/L003120/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/18/13/33946
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Chief Scientist Office
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/13/13/30194
Pays : United Kingdom

Références

Postma, D. S., Bush, A. & van den Berge, M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet 385, 899–909 (2015).
pubmed: 25123778
Barker, D. J. The origins of the developmental origins theory. J. Intern Med. 261, 412–417 (2007).
pubmed: 17444880
Gensollen, T., Iyer, S. S., Kasper, D. L. & Blumberg, R. S. How colonization by microbiota in early life shapes the immune system. Science 352, 539–544 (2016).
pubmed: 27126036 pmcid: 5050524
Reynolds, L. A. & Finlay, B. B. Early life factors that affect allergy development. Nat. Rev. Immunol. 17, 518–528 (2017).
pubmed: 28504257
Carraro, S., Scheltema, N., Bont, L. & Baraldi, E. Early-life origins of chronic respiratory diseases: understanding and promoting healthy ageing. Eur. Respir. J. 44, 1682–1696 (2014).
pubmed: 25323240
GTEx Consortium et al. Genetic effects on gene expression across human tissues. Nature 550, 204–213 (2017).
pmcid: 5776756
Schmiedel, B. J. et al. Impact of genetic polymorphisms on human immune cell gene expression. Cell 175, e16 (2018).
Peng, S. et al. Expression quantitative trait loci (eQTLs) in human placentas suggest developmental origins of complex diseases. Hum. Mol. Genet 26, 3432–3441 (2017).
pubmed: 28854703 pmcid: 5886245
O’Brien, H. E. et al. Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders. Genome Biol. 19, 194 (2018).
pubmed: 30419947 pmcid: 6231252
Fairfax, B. P. et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 343, 1246949 (2014).
pubmed: 24604202 pmcid: 4064786
Kim-Hellmuth, S. et al. Genetic regulatory effects modified by immune activation contribute to autoimmune disease associations. Nat. Commun. 8, 266 (2017).
pubmed: 28814792 pmcid: 5559603
Alasoo, K. et al. Shared genetic effects on chromatin and gene expression indicate a role for enhancer priming in immune response. Nat. Genet. 50, 424–431 (2018).
pubmed: 29379200 pmcid: 6548559
Lee, M. N. et al. Common genetic variants modulate pathogen-sensing responses in human dendritic cells. Science 343, 1246980 (2014).
pubmed: 24604203 pmcid: 4124741
Barreiro, L. B. et al. Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection. Proc. Natl Acad. Sci. USA 109, 1204–1209 (2012).
pubmed: 22233810
Ye, C. J. et al. Intersection of population variation and autoimmunity genetics in human T cell activation. Science 345, 1254665 (2014).
pubmed: 25214635 pmcid: 4751028
Kusel, M. M. et al. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr. Infect. Dis. J. 25, 680–686 (2006).
pubmed: 16874165
Kusel, M. M. et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J. Allergy Clin. Immunol. 119, 1105–1110 (2007).
pubmed: 17353039 pmcid: 7125611
Teo, S. M. et al. Airway microbiota dynamics uncover a critical window for interplay of pathogenic bacteria and allergy in childhood respiratory disease. Cell Host Microbe 24, e5 (2018).
Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773–782 (2019).
pubmed: 31061481 pmcid: 6610714
Urbut, S. M., Wang, G., Carbonetto, P. & Stephens, M. Flexible statistical methods for estimating and testing effects in genomic studies with multiple conditions. Nat. Genet 51, 187–195 (2019).
pubmed: 30478440
Iotchkova, V. et al. GARFIELD classifies disease-relevant genomic features through integration of functional annotations with association signals. Nat. Genet. 51, 343–353 (2019).
pubmed: 30692680 pmcid: 6908448
Chen, L. et al. Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells. Cell 167, e24 (2016).
Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA 100, 9440–9445 (2003).
pubmed: 12883005
Bryois, J. et al. Cis and trans effects of human genomic variants on gene expression. PLoS Genet. 10, e1004461 (2014).
pubmed: 25010687 pmcid: 4091791
Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 10, e1004383 (2014).
pubmed: 24830394 pmcid: 4022491
Roychoudhuri, R. et al. BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancers. Nat. Immunol. 17, 851–860 (2016).
pubmed: 27158840 pmcid: 4918801
Shinnakasu, R. et al. Regulated selection of germinal-center cells into the memory B cell compartment. Nat. Immunol. 17, 861–869 (2016).
Afzali, B. et al. BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency. Nat. Immunol. 18, 813–823 (2017).
pubmed: 28530713 pmcid: 5593426
Roychoudhuri, R. et al. BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature 498, 506–510 (2013).
pubmed: 23728300 pmcid: 3710737
Schutyser, E., Struyf, S. & Van Damme, J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14, 409–426 (2003).
pubmed: 12948524
Merk, M., Mitchell, R. A., Endres, S. & Bucala, R. D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family. Cytokine 59, 10–17 (2012).
pubmed: 22507380 pmcid: 3367028
Peters, J. E. et al. Insight into genotype-phenotype associations through eQTL mapping in multiple cell types in health and immune-mediated disease. PLoS Genet. 12, e1005908 (2016).
pubmed: 27015630 pmcid: 4807835
Pierce, B. L. et al. Mediation analysis demonstrates that trans-eQTLs are often explained by cis-mediation: a genome-wide analysis among 1,800 South Asians. PLoS Genet. 10, e1004818 (2014).
pubmed: 25474530 pmcid: 4256471
Yang, F., Wang, J., Consortium, G. T., Pierce, B. L. & Chen, L. S. Identifying cis-mediators for trans-eQTLs across many human tissues using genomic mediation analysis. Genome Res. 27, 1859–1871 (2017).
pubmed: 29021290 pmcid: 5668943
Ferretti, M. B., Ghalei, H., Ward, E. A., Potts, E. L. & Karbstein, K. Rps26 directs mRNA-specific translation by recognition of Kozak sequence elements. Nat. Struct. Mol. Biol. 24, 700–707 (2017).
pubmed: 28759050 pmcid: 5777333
Min, E. E., Roy, B., Amrani, N., He, F. & Jacobson, A. Yeast Upf1 CH domain interacts with Rps26 of the 40S ribosomal subunit. RNA 19, 1105–1115 (2013).
pubmed: 23801788 pmcid: 3708530
Cui, D. et al. The ribosomal protein S26 regulates p53 activity in response to DNA damage. Oncogene 33, 2225–2235 (2014).
pubmed: 23728348
Demedts, I. K. et al. Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 175, 998–1005 (2007).
pubmed: 17332482
Faiz, A. et al. Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1beta treatment: a novel role for CCL20 in chronic mucus hypersecretion. Eur. Respir. J. 52,1800310 (2018).
Kim, S., Lewis, C. & Nadel, J. A. CCL20/CCR6 feedback exaggerates epidermal growth factor receptor-dependent MUC5AC mucin production in human airway epithelial (NCI-H292) cells. J. Immunol. 186, 3392–3400 (2011).
pubmed: 21300824
Francis, J. N., Sabroe, I., Lloyd, C. M., Durham, S. R. & Till, S. J. Elevated CCR6+CD4+ T lymphocytes in tissue compared with blood and induction of CCL20 during the asthmatic late response. Clin. Exp. Immunol. 152, 440–447 (2008).
pubmed: 18422729 pmcid: 2453211
de Waal Malefyt, R. et al. Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol. 7, 1405–1416 (1995).
pubmed: 7495748
Punnonen, J. et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl Acad. Sci. USA 90, 3730–3734 (1993).
pubmed: 8097323
Wills-Karp, M. et al. Interleukin-13: central mediator of allergic asthma. Science 282, 2258–2261 (1998).
pubmed: 9856949
Berry, M. A. et al. Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J. Allergy Clin. Immunol. 114, 1106–1109 (2004).
pubmed: 15536417
Saha, S. K. et al. Increased sputum and bronchial biopsy IL-13 expression in severe asthma. J. Allergy Clin. Immunol. 121, 685–691 (2008).
pubmed: 18328894 pmcid: 3992379
Tsilogianni, Z. et al. Sputum interleukin-13 as a biomarker for the evaluation of asthma control. Clin. Exp. Allergy 46, 1498 (2016).
pubmed: 27790845
Guo, Y. & Wang, A. Y. Novel immune check-point regulators in tolerance maintenance. Front Immunol. 6, 421 (2015).
pubmed: 26347744 pmcid: 4539525
Le Page, C. et al. BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis. PLoS ONE 7, e38541 (2012).
pubmed: 22685580 pmcid: 3369854
Vavassori, S. et al. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human gammadelta T cells. Nat. Immunol. 14, 908–916 (2013).
pubmed: 23872678
Vantourout, P. et al. Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing gammadelta T cell biology. Proc. Natl Acad. Sci. USA 115, 1039–1044 (2018).
pubmed: 29339503
Lamontagne, M. et al. Leveraging lung tissue transcriptome to uncover candidate causal genes in COPD genetic associations. Hum. Mol. Genet. 27, 1819–1829 (2018).
pubmed: 29547942 pmcid: 5932553
Nair, R. P. et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am. J. Hum. Genet. 78, 827–851 (2006).
pubmed: 16642438 pmcid: 1474031
Genetic Analysis of Psoriasis, C. et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 42, 985–990 (2010).
Breen, M. S. et al. Gene expression in cord blood links genetic risk for neurodevelopmental disorders with maternal psychological distress and adverse childhood outcomes. Brain Behav. Immun. 73, 320–330 (2018).
pubmed: 29791872 pmcid: 6191930
Green, B. B. & Marsit, C. J. Select prenatal environmental exposures and subsequent alterations of gene-specific and repetitive element DNA methylation in fetal tissues. Curr. Environ. Health Rep. 2, 126–136 (2015).
pubmed: 26231362 pmcid: 4522706
Petit, T. et al. Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele-specific PCR amplification. Br. J. Haematol. 98, 767–771 (1997).
pubmed: 9332337
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
pubmed: 25605792 pmcid: 4402510
Arloth, J., Bader, D. M., Roh, S. & Altmann, A. Re-annotator: annotation pipeline for microarray probe sequences. PLoS ONE 10, e0139516 (2015).
pubmed: 26426330 pmcid: 4591122
Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284–1287 (2016).
pubmed: 27571263 pmcid: 5157836
Huang, Q. Q., Ritchie, S. C., Brozynska, M. & Inouye, M. Power, false discovery rate and Winner’s Curse in eQTL studies. Nucleic Acids Res. 46, e133 (2018).
pubmed: 30189032 pmcid: 6294523
Shabalin, A. A. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 28, 1353–1358 (2012).
pubmed: 22492648 pmcid: 3348564
Stegle, O., Parts, L., Piipari, M., Winn, J. & Durbin, R. Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses. Nat. Protoc. 7, 500–507 (2012).
pubmed: 22343431 pmcid: 3398141
Davis, J. R. et al. An efficient multiple-testing adjustment for eQTL studies that accounts for linkage disequilibrium between variants. Am. J. Hum. Genet. 98, 216–224 (2016).
pubmed: 26749306
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289–300 (1995).
Bates, D., Machler, M., Bolker, B. M. & Walker, S. C. Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, 1–48 (2015).
Davenport, E. E. et al. Discovering in vivo cytokine-eQTL interactions from a lupus clinical trial. Genome Biol. 19, 168 (2018).
pubmed: 30340504 pmcid: 6195724
Tingley, D., Yamamoto, T., Hirose, K., Keele, L. & Imai, K. mediation: R Package for causal mediation analysis. J. Stat. Softw. 59, 1–38 (2014).
Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 7, e34408 (2018).
Yavorska, O. O. & Burgess, S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J. Epidemiol. 46, 1734–1739 (2017).
pubmed: 28398548 pmcid: 5510723

Auteurs

Qin Qin Huang (QQ)

Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, 3004, Australia. qh1@sanger.ac.uk.
Department of Clinical Pathology, University of Melbourne, Parkville, VIC, 3010, Australia. qh1@sanger.ac.uk.
Department of Human Genetics, Wellcome Sanger Institute, Cambridge, UK. qh1@sanger.ac.uk.

Howard H F Tang (HHF)

Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, 3004, Australia.
School of BioSciences, The University of Melbourne, Parkville, VIC, 3010, Australia.

Shu Mei Teo (SM)

Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, 3004, Australia.
Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.

Danny Mok (D)

Telethon Kids Institute, The University of Western Australia, Perth, WA, 6009, Australia.

Scott C Ritchie (SC)

Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, 3004, Australia.
Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, UK.

Artika P Nath (AP)

Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, 3004, Australia.
Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.

Marta Brozynska (M)

Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, 3004, Australia.
Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.

Agus Salim (A)

Baker Heart and Diabetes Institute, Melbourne, VIC, 3004, Australia.
School of Mathematics and Statistics, The University of Melbourne, Parkville, VIC, 3010, Australia.
Melbourne School of Population and Global Health, Carlton, VIC, 3053, Australia.

Andrew Bakshi (A)

Monash Biomedicine Discovery Institute, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, 3800, Australia.

Barbara J Holt (BJ)

Telethon Kids Institute, The University of Western Australia, Perth, WA, 6009, Australia.

Chiea Chuen Khor (CC)

Human Genetics, Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore, 138672, Singapore.
Singapore Eye Research Institute, Singapore, Singapore.
Duke-NUS Medical School, Singapore, Singapore.

Peter D Sly (PD)

Child Health Research Centre, The University of Queensland, Brisbane, QLD, 4101, Australia.

Patrick G Holt (PG)

Telethon Kids Institute, The University of Western Australia, Perth, WA, 6009, Australia.
Child Health Research Centre, The University of Queensland, Brisbane, QLD, 4101, Australia.

Kathryn E Holt (KE)

Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC, 3004, Australia.
The London School of Hygiene and Tropical Medicine, London, WC1E 7TH, UK.

Michael Inouye (M)

Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, VIC, 3004, Australia. minouye@baker.edu.au.
Department of Clinical Pathology, University of Melbourne, Parkville, VIC, 3010, Australia. minouye@baker.edu.au.
Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK. minouye@baker.edu.au.
British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. minouye@baker.edu.au.
National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals, Cambridge, UK. minouye@baker.edu.au.
The Alan Turing Institute, London, UK. minouye@baker.edu.au.
British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK. minouye@baker.edu.au.
Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK. minouye@baker.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH